Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide is licensed as a once-weekly injection, and taking it twice a week is not recommended — the twice-weekly dose schedule simply does not exist in any approved UK product licence. The short answer is no; the longer answer explains why the once-weekly timing matters clinically and what to do if you feel your current dose is not working. As a prescription-only medicine, any change to how you take semaglutide must be agreed with your prescriber, who can assess whether the dose, formulation, or titration schedule needs adjusting. Wegovy (semaglutide) works by maintaining a steady level of the drug in your system over seven days; altering that rhythm is not a safe shortcut.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching this question are not looking to double their dose recklessly. They are usually at a point where weekly injections feel like they are not doing enough — appetite is returning by day five or six, weight loss has slowed, or they are comparing their progress to clinical trial figures and wondering if more frequent dosing would close the gap. That is a completely reasonable thing to wonder. The frustration is real, and it deserves a straight answer.
The short version is this: semaglutide's once-weekly design is not an arbitrary instruction. Its half-life sits close to seven days, which means a single injection maintains therapeutic concentrations in your blood across the full week. Injecting again at day three or four would stack doses before the first has cleared, pushing concentrations well beyond the therapeutic range. The clinical trials that demonstrated Wegovy's safety profile (including the STEP 1 study published in the New England Journal of Medicine) were built entirely on the once-weekly schedule, so safety and efficacy data outside that schedule simply do not exist. If you want a fuller explanation of why the schedule is fixed the way it is, our page on whether you can take Wegovy twice a week walks through the pharmacology in plain language.
There is also a practical point. Twice-weekly use would exhaust your pen supply in half the intended time. Pens are not interchangeable in that way, and attempting it would leave you without medicine for the second half of the month.
If weekly injections feel insufficient, the question your prescriber will ask is whether you are at the right dose for your body, not whether you should inject more often. The licensed titration path for Wegovy runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with each step taken roughly every four weeks. For patients on the standard 2.4 mg maintenance dose who still want more, the MHRA approved a higher 7.2 mg dose in 2026, which represents a meaningful step up in efficacy for suitable patients.
That is the lever your prescriber can pull: moving up the titration schedule at an appropriate pace, or discussing whether the higher maintenance dose is right for you. Changing the frequency is not on the licensed menu. Eligibility for semaglutide and the correct dose for your situation are determined by a clinical assessment of your health history, weight, and any conditions you are managing alongside treatment. Understanding the BMI criteria required to qualify for semaglutide is a useful starting point before that conversation with your prescriber.
If you have recently moved to a higher dose and the side effects feel significant, the instinct might be to spread doses out. That is worth raising with your prescriber too, sometimes a slower titration is the answer, not a change in frequency in either direction.
Mistakes happen. If you inject semaglutide and then realise you already injected a few days ago (or if you misread the day and took two doses within the same seven-day window) the NHS semaglutide guidance is clear: do not take an additional dose to compensate. Continue with your normal schedule from the next planned day. You may notice stronger gastrointestinal side effects: nausea, diarrhoea, and stomach discomfort are more likely when concentrations are higher than usual. These usually settle, but if symptoms are severe or persistent, contact a healthcare professional.
The same principle applies in reverse. If you miss a dose entirely and your next scheduled injection is more than five days away, you can take it late. If the gap is shorter, skip the missed dose and carry on. The full guidance on missed doses is worth reading before your first pen, knowing the rules in advance avoids a panicked decision mid-month.
One thing that catches people out: holidays, bank holidays, or a pay cycle that shifts the week you order. Payday falling on a Thursday and a bank holiday Monday can create a gap that feels like a missed dose situation when really your pen just arrived late. Plan a small buffer if your schedule is time-sensitive. Ordering online through a registered pharmacy with tracked next-working-day delivery helps, but it is still worth thinking ahead.
Some people find injections difficult, travel, needle anxiety, or a lifestyle where refrigerating a pen is genuinely awkward. From June 2026, Wegovy is also available as a daily oral tablet licensed for weight management in the UK, making it the first oral GLP-1 medicine approved here for that purpose. It follows a different schedule (once daily, on an empty stomach, starting at 1.5 mg and working up to 25 mg), so the twice-a-week question does not arise in the same way. Exploring which format suits your situation is something our prescribers discuss during consultation.
If you are weighing up whether Wegovy is right for you at all, including questions about BMI thresholds for Wegovy and how they compare to other treatments, the weight-loss treatment overview lays out the landscape clearly. For anything specific to your own health picture, speaking directly with a prescriber is the only route that will give you a reliable, personalised answer.
Speak to our prescribers if you are unsure whether your current schedule, dose, or format is working as it should.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.